Comment on $15M stock offering: Malvern pharma firm raising funds for experimental pain medicine

$15M stock offering: Malvern pharma firm raising funds for experimental pain medicine

Recro Pharma Inc. on Tuesday said it is seeking to raise $15 million in an public stock offering. The Malvern, Pennsylvania, specialty pharmaceutical company is selling just under 2 million shares of its common stock at $7.50 per share. Recro Pharma (Nasdaq: REPH) intends to use the bulk of the the net proceeds from the offering to fund ongoing late-stage testing of its injectable meloxicam pain relief medicine.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News